|
|||||
|
|
Cost‐Savings Analysis of AR‐V7 Testing in Patients With Metastatic Castration‐Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide |
|
| Authors: | Mark C. Markowski Kevin D. Frick James R. Eshleman Jun Luo Emmanuel S. Antonarakis |
| Affiliation: | 1. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;2. Johns Hopkins Carey Business School, Baltimore, Maryland;3. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland;4. Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland |
| Abstract: | |
| Keywords: | AR‐V7 testing CLIA‐certified cost savings healthcare costs prostate cancer |